Iran, Islamic Republic of vs Lebanon: Tuberculosis treatment success rate
Iran, Islamic Republic of
85.0%
in 2023
Lebanon
85.0%
in 2023
Iran, Islamic Republic of rank
89th
Lebanon rank
89th
Tuberculosis treatment success rate over time
- Iran, Islamic Republic of
- Lebanon
How they compare
Iran, Islamic Republic of currently reports 85.0% against 85.0% in Lebanon, a difference of 0.0%.
The two have swapped places 5 times across 28 shared years of data; in 1996 it was Iran, Islamic Republic of ahead.
Iran, Islamic Republic of ranks 89th and Lebanon ranks 89th of 206 countries.
Across the 4 decades both report, Iran, Islamic Republic of averaged higher in 2 and Lebanon in 2.
Head to head by decade
| Decade | Iran, Islamic Republic of | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 82.5% | 76.8% | 5.8% | Iran, Islamic Republic of |
| 2000s | 82.9% | 88.6% | 5.7% | Lebanon |
| 2010s | 85.8% | 79.0% | 6.8% | Iran, Islamic Republic of |
| 2020s | 84.0% | 84.8% | 0.8% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Iran, Islamic Republic of or Lebanon?
- Iran, Islamic Republic of, at 85.0% against 85.0% in Lebanon as of 2023.
- What is the difference in tuberculosis treatment success rate between Iran, Islamic Republic of and Lebanon?
- 0.0%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Lebanon?
- 28 years are reported by both, from 1996 to 2023.
- How do Iran, Islamic Republic of and Lebanon rank globally for tuberculosis treatment success rate?
- Iran, Islamic Republic of ranks 89th and Lebanon ranks 89th of 206 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.